oral microencapsulated diindolylmethane

DRUG3 trials

Sponsors

National Cancer Institute (NCI), Barts and the London School of Medicine and Dentistry, Barbara Ann Karmanos Cancer Institute

Conditions

Breast Cancer FemaleCervical CancerHealthy, no Evidence of DiseasePrecancerous Condition

Phase 1

Diindolylmethane in Healthy Volunteers

CompletedNCT00392652

National Cancer Institute (NCI)Healthy, no Evidence of Disease

Start: 2006-11-30End: 2009-10-31Updated: 2016-12-29

Phase 2

Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery

WithdrawnNCT01612910

Barbara Ann Karmanos Cancer InstituteBreast Cancer Female

Start: 2012-06-30End: 2014-02-28Updated: 2014-02-12

Phase 3

Diindolylmethane in Treating Patients With Abnormal Cervical Cells

CompletedNCT00462813

Barts and the London School of Medicine and DentistryCervical Cancer, Precancerous Condition

Start: 2004-10-31End: 2010-01-31Target: 3000Updated: 2013-08-07